Insulet
PODD
#1045
Rank
NZ$31.47 B
Marketcap
$448.71
Share price
9.40%
Change (1 day)
70.31%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): NZ$0.49 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$1.87 Billion. In 2023 the company made an earning of NZ$0.41 Billion, an increase over its 2022 earnings that were of NZ$72.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.49 B19.04%
2023 NZ$0.41 B481.9%
2022 NZ$72.16 M-45.24%
2021 NZ$0.13 B43.35%
2020 NZ$91.91 M18.51%
2019 NZ$77.56 M41.16%
2018 NZ$54.94 M-711.95%
2017 -NZ$8.98 Million-56.85%
2016 -NZ$20.82 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$61.4 Million31.04%
2013 -NZ$46.86 Million-21.96%
2012 -NZ$60.05 Million
2010 -NZ$57.27 Million-42.38%
2009 -NZ$99.39 Million-33.56%
2008 -NZ$0.15 Billion65.93%
2007 -NZ$90.15 Million209.75%
2006 -NZ$29.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$12.29 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.23 Billion-144.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.27 B 149.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.79 B 5,905.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.34 B 2,112.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$9.45 B 1,742.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$16.99 B 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA